Cityblock Health was founded in 2017 by Bay Gross, Iyah Romm, Mat Balez, Melanie Bella, and Toyin Ajayi. The company has not officially endorsed a plan to participate in an IPO. These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Cityblock Health is a primary care provider whose services include both physical and mental healthcare. The company operates both virtually and in-office, and maintains a focus on serving underrepresented communities. As of 2022, the company operates in five states as well as Washington D.C. Cityblock has raised nearly $900 million in venture capital funding from investors including SoftBank Capital, Wellington Management, Tiger Global Management, Thrive Capital, Redpoint, Goldman Sachs Asset Management, and General Catalyst. As of 2021, the company has achieved a post-money valuation of $5.7 billion.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/18/2024 | Series X | $39MM | $xx.xx | $157.5B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,958,910
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
09/03/2021 | Series D-2 | $75MM | $xx.xx | $622.31B | Softbank | |
Price per Share
$xx.xx
Shares Outstanding
951,062
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Softbank
|
||||||
09/03/2021 | Series D-1 | $325MM | $xx.xx | $622.31B | Softbank | |
Price per Share
$xx.xx
Shares Outstanding
4,121,305
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Softbank
|
||||||
03/29/2021 | Series C-2 | $192.25MM | $xx.xx | $299.58B | 8vc, Aims Imprint, Echo Health Ventures, General Catalyst, Kinnevik Ab, Maverick Ventures, Redpoint Ventures, Thrive Capital, Tiger Global Management, Wellington Management | |
Price per Share
$xx.xx
Shares Outstanding
4,627,368
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
8vc, Aims Imprint, Echo Health Ventures, General Catalyst, Kinnevik Ab, Maverick Ventures, Redpoint Ventures, Thrive Capital, Tiger Global Management, Wellington Management
|
||||||
12/09/2020 | Series C | $160MM | $xx.xx | $126.14B | General Catalyst, Kinnevik Ab, Maverick Ventures, Redpoint Ventures, Thrive Capital, Wellington Management | |
Price per Share
$xx.xx
Shares Outstanding
7,998,481
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
General Catalyst, Kinnevik Ab, Maverick Ventures, Redpoint Ventures, Thrive Capital, Wellington Management
|
||||||
06/17/2020 | Series B+ | $53.31MM | $xx.xx | $33.35B | 8vc, Aims, Alphabet, Echo Health Ventures, Emblem Health, Kinnevik Ab, Maverick Ventures, Redpoint Ventures, Thrive Capital, Town Hall Ventures | |
Price per Share
$xx.xx
Shares Outstanding
9,046,862
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
8vc, Aims, Alphabet, Echo Health Ventures, Emblem Health, Kinnevik Ab, Maverick Ventures, Redpoint Ventures, Thrive Capital, Town Hall Ventures
|
||||||
03/29/2019 | Series B-2 | $2.53MM | $xx.xx | $23.41B | 8vc, Echo Health Ventures, Emblemhealth, Maverick Ventures, Redpoint Ventures, Sidewalk Labs, Startup Health, Thrive Capital, Town Hall Ventures | |
Price per Share
$xx.xx
Shares Outstanding
1,439,462
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
8vc, Echo Health Ventures, Emblemhealth, Maverick Ventures, Redpoint Ventures, Sidewalk Labs, Startup Health, Thrive Capital, Town Hall Ventures
|
||||||
03/29/2019 | Series B-3 | $5.01MM | $xx.xx | $23.41B | 8vc, Echo Health Ventures, Emblemhealth, Maverick Ventures, Redpoint Ventures, Sidewalk Labs, Startup Health, Thrive Capital, Town Hall Ventures | |
Price per Share
$xx.xx
Shares Outstanding
1,501,217
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
8vc, Echo Health Ventures, Emblemhealth, Maverick Ventures, Redpoint Ventures, Sidewalk Labs, Startup Health, Thrive Capital, Town Hall Ventures
|
||||||
03/29/2019 | Series B-1 | $57.55MM | $xx.xx | $23.41B | 8vc, Echo Health Ventures, Emblemhealth, Maverick Ventures, Redpoint Ventures, Sidewalk Labs, Startup Health, Thrive Capital, Town Hall Ventures | |
Price per Share
$xx.xx
Shares Outstanding
10,949,808
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
8vc, Echo Health Ventures, Emblemhealth, Maverick Ventures, Redpoint Ventures, Sidewalk Labs, Startup Health, Thrive Capital, Town Hall Ventures
|
||||||
01/04/2018 | Series A | $20.79MM | $xx.xx | $3.99B | Maverick Ventures, Sidewalk Labs, Thrive Capital | |
Price per Share
$xx.xx
Shares Outstanding
14,510,040
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Maverick Ventures, Sidewalk Labs, Thrive Capital
|
||||||
09/19/2017 | Series Seed | $2.4MM | $xx.xx | $600MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|